The combination of gefitinib and RAD001 inhibits growth of HER2 overexpressing breast cancer cells and tumors irrespective of trastuzumab sensitivity

por Dragowska, Wieslawa H, Weppler, Sherry A, Qadir, Mohammed A, Wong, Ling Yan, Franssen, Yannick, Baker, Jennifer HE, Kapanen, Anita I, Kierkels, Guido JJ, Masin, Dana, Minchinton, Andrew I, Gelmon, Karen A, Bally, Marcel B
Publicado 2011

Induction of Autophagy Is an Early Response to Gefitinib and a Potential Therapeutic Target in Breast Cancer

por Dragowska, Wieslawa H., Weppler, Sherry A., Wang, Jun Chih, Wong, Ling Yan, Kapanen, Anita I., Rawji, Jenna S., Warburton, Corinna, Qadir, Mohammed A., Donohue, Elizabeth, Roberge, Michel, Gorski, Sharon M., Gelmon, Karen A., Bally, Marcel B.
Publicado 2013